Evidence map›Paper›PMID 22250027›Full record

ArticlePediatrics2012

Maternal asthma medication use and the risk of selected birth defects.

Shao Lin, Jean Pierre W Munsie, Michele L Herdt-Losavio, Charlotte M Druschel, Kimberly Campbell, Marilyn L Browne, Paul A Romitti, Richard S Olney, Erin M Bell, National Birth Defects Prevention Study

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Anorectal malformation: the etiological factors.Pediatric surgery international · 2015
    Review
  13. Article
  14. Asthma in pregnancy: a hit for two.European respiratory review : an official journal of the European Respiratory Society · 2014
    Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shao LinCenter for Environmental Health, New York State Department of Health, Troy, NY, USA.
Jean Pierre W Munsie
Michele L Herdt-Losavio
Charlotte M Druschel
Kimberly Campbell
Marilyn L Browne
Paul A Romitti
Richard S Olney
Erin M Bell
National Birth Defects Prevention Study

Funding

Iowa Center for Birth Defects Research and Prevention (ICBDRP)U01DD000492 · DD · UNIVERSITY OF IOWA · PI ROMITTI, PAUL A · 2009 to 2013
$3.9M
COOPERATIVE AGREEMENTS FOR THE CENTERS FOR BIRTH DEFECTS RESEARCH AND PREVU50DD223184 · DD · NYSDOH/HEALTH RESEARCH, INC. · PI DRUSCHEL, CHARLOTTE MARIE · 2003 to 2008
$2.1M
NCBDD CDC HHS U01 DD000492NCBDD CDC HHS U50 DD223184PHS HHS U50/CCU223184
6 · The paper itself

Abstract

objectivesApproximately 4% to 12% of pregnant women have asthma; few studies have examined the effects of maternal asthma medication use on birth defects. We examined whether maternal asthma medication use during early pregnancy increased the risk of selected birth defects.

methodsNational Birth Defects Prevention Study data for 2853 infants with 1 or more selected birth defects (diaphragmatic hernia, esophageal atresia, small intestinal atresia, anorectal atresia, neural tube defects, omphalocele, or limb deficiencies) and 6726 unaffected control infants delivered from October 1997 through December 2005 were analyzed. Mothers of cases and controls provided telephone interviews of medication use and additional potential risk factors. Exposure was defined as maternal periconceptional (1 month prior through the third month of pregnancy) asthma medication use (bronchodilator or anti-inflammatory). Associations between maternal periconceptional asthma medication use and individual major birth defects were estimated by using adjusted odds ratios (aOR) and 95% confidence intervals (95%CI).

resultsNo statistically significant associations were observed for maternal periconceptional asthma medication use and most defects studied; however, positive associations were observed between maternal asthma medication use and isolated esophageal atresia (bronchodilator use: aOR = 2.39, 95%CI = 1.23, 4.66), isolated anorectal atresia (anti-inflammatory use: aOR = 2.12, 95%CI = 1.09, 4.12), and omphalocele (bronchodilator and anti-inflammatory use: aOR = 4.13, 95%CI = 1.43, 11.95).

conclusionsPositive associations were observed for anorectal atresia, esophageal atresia, and omphalocele and maternal periconceptional asthma medication use, but not for other defects studied. It is possible that observed associations may be chance findings or may be a result of maternal asthma severity and related hypoxia rather than medication use.

Indexed as

Abnormalities, Drug-InducedAdultAlbuterolAnal CanalAndrostadienesAnti-Asthmatic AgentsAnti-Inflammatory AgentsAnus, ImperforateAsthmaBeclomethasoneBronchodilator AgentsCase-Control StudiesEsophagusFemaleFluticasoneHeart Defects, CongenitalAlbuterolAndrostadienesAnti-Asthmatic AgentsAnti-Inflammatory AgentsBeclomethasoneBronchodilator AgentsFluticasone

Identifiers

PMID22250027
PMCPMC5893143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.